Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. West · SciRah

Researcher profile · Semantic Scholar

C. West

Share profile

C. West — researcher profile on SciRah

h-index: 28
Works: 80
Citations: 2,907

Most-cited papers

Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial.
Mark T. Brown, F. Murphy, D. Radin, I. Davignon +2 more
2012Journal of Pain211 citations Open access
Semantic Scholar
Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
W. White, C. West, J. Borer, P. Gorelick +4 more
2007American Journal of Cardiology199 citations
Semantic Scholar
Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
T. Schnitzer, Richard W. Easton, Shirley Pang, D. Levinson +6 more
2019Journal of the American Medical Association (JAMA)182 citations Open access
Semantic Scholar
When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program
M. Hochberg, Leslie A. Tive, Steven B. Abramson, E. Vignon +4 more
2016Arthritis & Rheumatology161 citations
Semantic Scholar
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period
F. Berenbaum, F. Blanco, A. Guermazi, K. Miki +7 more
2020Annals of the Rheumatic Diseases156 citations Open access
Semantic Scholar
Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
T. Schnitzer, E. Ekman, E. Spierings, H. S. Greenberg +4 more
2015Annals of the Rheumatic Diseases147 citations
Semantic Scholar
Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain
A. Kivitz, J. Gimbel, C. Bramson, Mary Anne Nemeth +4 more
2013Pain139 citations
Semantic Scholar
Long-Term Efficacy and Safety of Celecoxib in Alzheimer’s Disease
H. Soininen, C. West, J. Robbins, L. Niculescu
2006Dementia and Geriatric Cognitive Disorders131 citations
Semantic Scholar
Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial.
Mark T. Brown, F. Murphy, D. Radin, I. Davignon +2 more
2013Arthritis & Rheumatism128 citations
Semantic Scholar
A phase III placebo‐ and oxycodone‐controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee
E. Spierings, J. Fidelholtz, Gernot Wolfram, Michael D. Smith +2 more
2013Pain128 citations
Semantic Scholar
Comprehensive Review Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations
S. Cooper, P. Desjardins, D. Turk, R. Dworkin +28 more
103 citations
Semantic Scholar
Efficacy and Safety of Intravenous Tanezumab for the Symptomatic Treatment of Osteoarthritis: 2 Randomized Controlled Trials versus Naproxen
E. Ekman, J. Gimbel, A. Bello, Michael D. Smith +5 more
2014Journal of Rheumatology90 citations Open access
Semantic Scholar
Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial
A. Bălănescu, E. Feist, Gernot Wolfram, I. Davignon +3 more
2013Annals of the Rheumatic Diseases80 citations
Semantic Scholar
Long‐Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial
M. Hochberg, J. Carrino, T. Schnitzer, A. Guermazi +10 more
2021Arthritis & Rheumatology75 citations
Semantic Scholar
Efficacy and safety of tanezumab in the treatment of pain from bone metastases
M. Sopata, N. Katz, W. Carey, Michael D. Smith +5 more
2015Pain73 citations
Semantic Scholar
A Prospective Study Comparing Celecoxib with Naproxen in Children with Juvenile Rheumatoid Arthritis
I. Foeldvari, I. Szer, L. Zemel, D. Lovell +6 more
2008Journal of Rheumatology64 citations Open access
Semantic Scholar
Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen.
Andrew Whelton, J. Lefkowith, C. West, K. Verburg
2006Kidney International57 citations Open access
Semantic Scholar
A Randomized Placebo-Controlled Trial of the Anti-Nerve Growth Factor Antibody Tanezumab in Subjects With Cancer Pain Due to Bone Metastasis.
M. Fallon, M. Sopata, E. Dragon, Mark T. Brown +4 more
2023The Oncologist55 citations Open access
Semantic Scholar
Long‐term safety and effectiveness of tanezumab as treatment for chronic low back pain
J. Gimbel, A. Kivitz, C. Bramson, Mary Anne Nemeth +4 more
2014Pain54 citations
Semantic Scholar
Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety
J. Markman, Robert B. Bolash, T. McAlindon, A. Kivitz +8 more
2020Pain51 citations Open access
Semantic Scholar
Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip
L. Tive, A. Bello, D. Radin, T. Schnitzer +3 more
2019Journal of Pain Research49 citations Open access
Semantic Scholar
Nerve safety of tanezumab, a nerve growth factor inhibitor for pain treatment.
Mark T. Brown, D. Herrmann, M. Goldstein, A. Burr +4 more
2014Journal of Neurological Sciences44 citations
Semantic Scholar
A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
A. Kivitz, L. Espinoza, Y. Sherrer, M. Liu-Dumaw +1 more
2007Seminars in Arthritis & Rheumatism44 citations
Semantic Scholar
NEUROPATHIC PAIN SECTION Original Research Article Exploring the Role of Tanezumab as a Novel Treatment for the Relief of Neuropathic Pain
C. Bramson, D. Herrmann, W. Carey, D. S. Keller +4 more
201643 citations
Semantic Scholar
Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis
C. Birbara, E. Dabezies, A. Burr, R. Fountaine +5 more
2018Journal of Pain Research39 citations Open access
Semantic Scholar
Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
S. Daniels, J. Robbins, C. West, Mary Anne Nemeth
2009Clinical Therapeutics36 citations
Semantic Scholar
Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab.
J. A. Carrino, T. McAlindon, T. Schnitzer, A. Guermazi +9 more
2023Osteoarthritis and Cartilage32 citations Open access
Semantic Scholar
Preliminary development of a responder index for chronic low back pain.
L. Simon, C. Evans, N. Katz, C. Bombardier +5 more
2007Journal of Rheumatology32 citations
Semantic Scholar
Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study
T. Neogi, D. Hunter, M. Churchill, I. Shirinsky +9 more
2022Arthritis Research & Therapy26 citations Open access
Semantic Scholar
Exploring the role of tanezumab as a novel treatment for the relief of neuropathic pain.
C. Bramson, David N Herrmann, W. Carey, David Keller +4 more
2015Pain medicine (Malden, Mass.)24 citations Open access
Semantic Scholar
Serological biomarker profiles of rapidly progressive osteoarthritis in tanezumab-treated patients.
M. Karsdal, K. Verburg, C. West, A. Bay-Jensen +2 more
2019Osteoarthritis and Cartilage23 citations Open access
Semantic Scholar
Development of pain therapies targeting nerve growth factor signal transduction and the strategies used to resolve safety issues.
P. Bélanger, C. West, Mark T. Brown
2018Journal of Toxicological Sciences20 citations Open access
Semantic Scholar
Identification of serological biomarker profiles associated with total joint replacement in osteoarthritis patients.
R. Arends, M. Karsdal, K. Verburg, C. West +2 more
2014Osteoarthritis and Cartilage20 citations Open access
Semantic Scholar
Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study.
T. Schnitzer, Arif-ullah Khan, Louis Bessette, I. Davignon +6 more
2020Seminars in Arthritis & Rheumatism16 citations Open access
Semantic Scholar
First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain
P. Walicke, F. Hefti, Roxanne Bales, Shiao-Ping Lu +4 more
2018PAIN Reports14 citations Open access
Semantic Scholar
Development of an imaging mitigation strategy for patient enrolment in the tanezumab nerve growth factor inhibitor (NGF-ab) program with a focus on eligibility assessment.
F. Roemer, Colin G. Miller, C. West, Mark T. Brown +6 more
2017Seminars in Arthritis & Rheumatism14 citations
Semantic Scholar
A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee: response.
E. Spierings, J. Fidelholtz, Gernot Wolfram, Michael D. Smith +2 more
2014Pain14 citations
Semantic Scholar
Dosing Celecoxib in Pediatric Patients With Juvenile Rheumatoid Arthritis
S. Krishnaswami, M. Hutmacher, J. Robbins, A. Bello +2 more
2012Journal of clinical pharmacology14 citations
Semantic Scholar
Efficacy and safety of intravenous tanezumab in osteoarthritis hip and knee pain: comparison to placebo and naproxen in two phase III studies (NCT00830063 & NCT00863304)
E. Ekman, J. Gimbel, A. Bello, Michael D. Smith +5 more
201113 citations Open access
Semantic Scholar
Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase Ill Tanezumab Randomized Clinical Trials
L. Colloca, R. Dworkin, John T. Farrar, L. Tive +8 more
2023Clinical pharmacology and therapy12 citations Open access
Semantic Scholar
General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials
F. Berenbaum, T. Schnitzer, A. Kivitz, L. Viktrup +5 more
2021Arthritis care & research11 citations Open access
Semantic Scholar
Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety study.
S. Konno, T. Nikaido, J. Markman, M. Ohta +7 more
2021Pain Management11 citations Open access
Semantic Scholar
Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?
F. Berenbaum, R. Langford, S. Perrot, K. Miki +9 more
2021European Journal of Pain10 citations Open access
Semantic Scholar
Neurological safety of subcutaneous tanezumab versus NSAID in patients with osteoarthritis.
Mark T. Brown, P. Sandroni, P. Low, K. Gorson +6 more
2022Journal of Neurological Sciences8 citations Open access
Semantic Scholar
Efficacy and safety of subcutaneous tanezumab in patients with pain related to diabetic peripheral neuropathy (NCT01087203)
C. Bramson, D. Herrmann, V. Biton, W. Carey +5 more
20138 citations Open access
Semantic Scholar
Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 Trial
J. Markman, T. Schnitzer, S. Perrot, S. Beydoun +6 more
2022Pain and Therapy7 citations Open access
Semantic Scholar
Tanezumab Does Not Cause Sympathetic Nervous System Dysfunction in Clinical Osteoarthritis Studies (P3.303)
Mark T. Brown, M. Koltzenburg, Ha Nguyen, C. West +1 more
2015Neurology7 citations
Semantic Scholar
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis
Mark T. Brown, D. Cornblath, M. Koltzenburg, K. Gorson +5 more
2023Clinical drug investigation5 citations Open access
Semantic Scholar
A standard database format for clinical trials of pain treatments: An ACTTION–CDISC initiative
R. Dworkin, Robert R. Allen, Stephen Kopko, Yun Lu +18 more
2013Pain5 citations
Semantic Scholar
Inter-Reader Consistency and Exclusionary Findings During Radiographic Screening for Phase 3 Trials of Tanezumab in Patients With Osteoarthritis
A. Guermazi, F. Roemer, Andrew J. Kompel, L. Diaz +9 more
2022Osteoarthritis Imaging4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Verburg×28
Invite
K. Verburg — researcher profile on SciRah
Mark T. Brown×25
Invite
Mark T. Brown — researcher profile on SciRah
L. Viktrup×16
Invite
L. Viktrup — researcher profile on SciRah
Michael D. Smith×12
Invite
Michael D. Smith — researcher profile on SciRah

×10

Invite

Mark T. Brown — researcher profile on SciRah

Invite

G. Pixton — researcher profile on SciRah

D. S. Keller×9

Invite

D. S. Keller — researcher profile on SciRah

T. Schnitzer×8

Invite

T. Schnitzer — researcher profile on SciRah

Invite

C. Bramson — researcher profile on SciRah

Invite

I. Davignon — researcher profile on SciRah

Invite

A. Guermazi — researcher profile on SciRah

Invite

W. Carey — researcher profile on SciRah